Clinical Trial Update: Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection.

View source ↗

Summary

This trial evaluated whether donor-derived cell-free DNA provides added clinical value for monitoring cardiac allograft rejection after heart transplantation; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Rejection
• Heart Transplantation

Snippet

Sponsor: Paris Translational Research Center for Organ Transplantation | Conditions: Heart Transplantation, Rejection Heart Transplant | Status: COMPLETED